Phase 3 study of subcutaneously-administered SK-1401 in patients with non-dialysis chronic kidney disease
Latest Information Update: 09 Dec 2021
At a glance
- Drugs Darbepoetin alfa (Primary)
- Indications Renal failure
- Focus Therapeutic Use
- Sponsors Sanwa Kagaku Kenkyusho
- 09 Dec 2021 New trial record